Successful management of intralenticular Ozurdex injection causing cataract and intractable glaucoma
暂无分享,去创建一个
[1] M. Şekeroğlu,et al. Intralenticular Sustained-Release Dexamethasone Implant: Is It Still Effective on Macular Edema? , 2016, Case Reports in Ophthalmology.
[2] F. Bandello,et al. Accidental injection of dexamethasone intravitreal implant in the crystalline lens , 2014, Acta ophthalmologica.
[3] J. García-Martínez,et al. Accidental Injections of Dexamethasone Intravitreal Implant (Ozurdex®) into the Crystalline Lens , 2014, European journal of ophthalmology.
[4] C. Roșca,et al. Repositioning and follow-up of intralenticular dexamethasone implant. , 2013, Journal of cataract and refractive surgery.
[5] R. Roy,et al. Split Ozurdex implant: a caution. , 2013, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[6] A. Agarwal,et al. Phacoemulsification and intraocular lens implantation after inadvertent intracapsular injection of intravitreal dexamethasone implant , 2012, BMJ Case Reports.
[7] L. Wheeler,et al. Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant. , 2011, Investigative ophthalmology & visual science.
[8] S. Whitcup,et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. , 2010, Investigative ophthalmology & visual science.
[9] Jane S. Myung,et al. Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant , 2010, Clinical ophthalmology.
[10] George A. Williams,et al. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. , 2010, Archives of ophthalmology.